- Home
- RSSS vs UNCY Comparison
RSSS vs UNCY Comparison
Compare RSSS & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- UNCY
- Stock Information
- Founded
- RSSS 2006
- UNCY 2016
- Country
- RSSS United States
- UNCY United States
- Employees
- RSSS N/A
- UNCY N/A
- Industry
- RSSS Business Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- UNCY Health Care
- Exchange
- RSSS Nasdaq
- UNCY Nasdaq
- Market Cap
- RSSS 90.6M
- UNCY 74.2M
- IPO Year
- RSSS N/A
- UNCY 2021
- Fundamental
- Price
- RSSS $3.37
- UNCY $3.94
- Analyst Decision
- RSSS
- UNCY Strong Buy
- Analyst Count
- RSSS 0
- UNCY 5
- Target Price
- RSSS N/A
- UNCY $55.20
- AVG Volume (30 Days)
- RSSS 62.9K
- UNCY 520.0K
- Earning Date
- RSSS 11-13-2025
- UNCY 11-12-2025
- Dividend Yield
- RSSS N/A
- UNCY N/A
- EPS Growth
- RSSS N/A
- UNCY N/A
- EPS
- RSSS N/A
- UNCY N/A
- Revenue
- RSSS $48,753,578.00
- UNCY N/A
- Revenue This Year
- RSSS $12.13
- UNCY N/A
- Revenue Next Year
- RSSS $6.34
- UNCY $4,481.14
- P/E Ratio
- RSSS N/A
- UNCY N/A
- Revenue Growth
- RSSS 14.85
- UNCY N/A
- 52 Week Low
- RSSS $2.32
- UNCY $3.40
- 52 Week High
- RSSS $4.24
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- RSSS 68.42
- UNCY 37.53
- Support Level
- RSSS $2.96
- UNCY $4.23
- Resistance Level
- RSSS $3.39
- UNCY $4.43
- Average True Range (ATR)
- RSSS 0.13
- UNCY 0.19
- MACD
- RSSS 0.01
- UNCY -0.01
- Stochastic Oscillator
- RSSS 95.35
- UNCY 22.22
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.